Global and United States Bioengineered Protein Drugs Market Insights, Forecast to 2026

    • ID: AR2972549
    • 06 October, 2020
    • Other
    • Region: Global
    • 128 Pages
    • QYResearch

    1 Study Coverage

    • 1.1 Bioengineered Protein Drugs Product Introduction
    • 1.2 Market Segments
    • 1.3 Key Bioengineered Protein Drugs Manufacturers Covered: Ranking by Revenue
    • 1.4 Market by Type
      • 1.4.1 Global Bioengineered Protein Drugs Market Size Growth Rate by Type
      • 1.4.2 Recombinant protein drugs
      • 1.4.3 Peptide hormones
      • 1.4.4 Vaccines
      • 1.4.5 Therapeutic enzymes
      • 1.4.6 Monoclonal antibodies
      • 1.4.7 Cytokines
      • 1.4.8 Replacement proteins
      • 1.4.9 Peptide antibiotics
      • 1.4.10 Blood products
    • 1.5 Market by Application
      • 1.5.1 Global Bioengineered Protein Drugs Market Size Growth Rate by Application
      • 1.5.2 Fractionation
      • 1.5.3 Bioreactors and microbial cell fermentation
      • 1.5.4 Genetic engineering
      • 1.5.5 Genetically modified organisms
      • 1.5.6 Pharming
      • 1.5.7 Bioengineered protein drugs produced by transgenic microorganisms, plants and animals
      • 1.5.8 Cell culture
      • 1.5.9 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Bioengineered Protein Drugs Market Size, Estimates and Forecasts
      • 2.1.1 Global Bioengineered Protein Drugs Revenue 2015-2026
      • 2.1.2 Global Bioengineered Protein Drugs Sales 2015-2026
    • 2.2 Global Bioengineered Protein Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
    • 2.3 Bioengineered Protein Drugs Historical Market Size by Region (2015-2020)
      • 2.3.1 Global Bioengineered Protein Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
      • 2.3.2 Global Bioengineered Protein Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
    • 2.4 Bioengineered Protein Drugs Market Estimates and Projections by Region (2021-2026)
      • 2.4.1 Global Bioengineered Protein Drugs Sales Forecast by Region (2021-2026)
      • 2.4.2 Global Bioengineered Protein Drugs Revenue Forecast by Region (2021-2026)

    3 Global Bioengineered Protein Drugs Competitor Landscape by Players

    • 3.1 Global Top Bioengineered Protein Drugs Sales by Manufacturers
      • 3.1.1 Global Bioengineered Protein Drugs Sales by Manufacturers (2015-2020)
      • 3.1.2 Global Bioengineered Protein Drugs Sales Market Share by Manufacturers (2015-2020)
    • 3.2 Global Bioengineered Protein Drugs Manufacturers by Revenue
      • 3.2.1 Global Bioengineered Protein Drugs Revenue by Manufacturers (2015-2020)
      • 3.2.2 Global Bioengineered Protein Drugs Revenue Share by Manufacturers (2015-2020)
      • 3.2.3 Global Bioengineered Protein Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
      • 3.2.4 Global Top 10 and Top 5 Companies by Bioengineered Protein Drugs Revenue in 2019
      • 3.2.5 Global Bioengineered Protein Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    • 3.3 Global Bioengineered Protein Drugs Price by Manufacturers
    • 3.4 Global Bioengineered Protein Drugs Manufacturing Base Distribution, Product Types
      • 3.4.1 Bioengineered Protein Drugs Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Bioengineered Protein Drugs Product Type
      • 3.4.3 Date of International Manufacturers Enter into Bioengineered Protein Drugs Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type (2015-2026)

    • 4.1 Global Bioengineered Protein Drugs Market Size by Type (2015-2020)
      • 4.1.1 Global Bioengineered Protein Drugs Sales by Type (2015-2020)
      • 4.1.2 Global Bioengineered Protein Drugs Revenue by Type (2015-2020)
      • 4.1.3 Bioengineered Protein Drugs Average Selling Price (ASP) by Type (2015-2026)
    • 4.2 Global Bioengineered Protein Drugs Market Size Forecast by Type (2021-2026)
      • 4.2.1 Global Bioengineered Protein Drugs Sales Forecast by Type (2021-2026)
      • 4.2.2 Global Bioengineered Protein Drugs Revenue Forecast by Type (2021-2026)
      • 4.2.3 Bioengineered Protein Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
    • 4.3 Global Bioengineered Protein Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

    5 Market Size by Application (2015-2026)

    • 5.1 Global Bioengineered Protein Drugs Market Size by Application (2015-2020)
      • 5.1.1 Global Bioengineered Protein Drugs Sales by Application (2015-2020)
      • 5.1.2 Global Bioengineered Protein Drugs Revenue by Application (2015-2020)
      • 5.1.3 Bioengineered Protein Drugs Price by Application (2015-2020)
    • 5.2 Bioengineered Protein Drugs Market Size Forecast by Application (2021-2026)
      • 5.2.1 Global Bioengineered Protein Drugs Sales Forecast by Application (2021-2026)
      • 5.2.2 Global Bioengineered Protein Drugs Revenue Forecast by Application (2021-2026)
      • 5.2.3 Global Bioengineered Protein Drugs Price Forecast by Application (2021-2026)

    6 United States by Players, Type and Application

    • 6.1 United States Bioengineered Protein Drugs Market Size YoY Growth 2015-2026
      • 6.1.1 United States Bioengineered Protein Drugs Sales YoY Growth 2015-2026
      • 6.1.2 United States Bioengineered Protein Drugs Revenue YoY Growth 2015-2026
      • 6.1.3 United States Bioengineered Protein Drugs Market Share in Global Market 2015-2026
    • 6.2 United States Bioengineered Protein Drugs Market Size by Players (International and Local Players)
      • 6.2.1 United States Top Bioengineered Protein Drugs Players by Sales (2015-2020)
      • 6.2.2 United States Top Bioengineered Protein Drugs Players by Revenue (2015-2020)
    • 6.3 United States Bioengineered Protein Drugs Historic Market Review by Type (2015-2020)
      • 6.3.1 United States Bioengineered Protein Drugs Sales Market Share by Type (2015-2020)
      • 6.3.2 United States Bioengineered Protein Drugs Revenue Market Share by Type (2015-2020)
      • 6.3.3 United States Bioengineered Protein Drugs Price by Type (2015-2020)
    • 6.4 United States Bioengineered Protein Drugs Market Estimates and Forecasts by Type (2021-2026)
      • 6.4.1 United States Bioengineered Protein Drugs Sales Forecast by Type (2021-2026)
      • 6.4.2 United States Bioengineered Protein Drugs Revenue Forecast by Type (2021-2026)
      • 6.4.3 United States Bioengineered Protein Drugs Price Forecast by Type (2021-2026)
    • 6.5 United States Bioengineered Protein Drugs Historic Market Review by Application (2015-2020)
      • 6.5.1 United States Bioengineered Protein Drugs Sales Market Share by Application (2015-2020)
      • 6.5.2 United States Bioengineered Protein Drugs Revenue Market Share by Application (2015-2020)
      • 6.5.3 United States Bioengineered Protein Drugs Price by Application (2015-2020)
    • 6.6 United States Bioengineered Protein Drugs Market Estimates and Forecasts by Application (2021-2026)
      • 6.6.1 United States Bioengineered Protein Drugs Sales Forecast by Application (2021-2026)
      • 6.6.2 United States Bioengineered Protein Drugs Revenue Forecast by Application (2021-2026)
      • 6.6.3 United States Bioengineered Protein Drugs Price Forecast by Application (2021-2026)

    7 North America

    • 7.1 North America Bioengineered Protein Drugs Market Size YoY Growth 2015-2026
    • 7.2 North America Bioengineered Protein Drugs Market Facts & Figures by Country
      • 7.2.1 North America Bioengineered Protein Drugs Sales by Country (2015-2020)
      • 7.2.2 North America Bioengineered Protein Drugs Revenue by Country (2015-2020)
      • 7.2.3 U.S.
      • 7.2.4 Canada

    8 Europe

    • 8.1 Europe Bioengineered Protein Drugs Market Size YoY Growth 2015-2026
    • 8.2 Europe Bioengineered Protein Drugs Market Facts & Figures by Country
      • 8.2.1 Europe Bioengineered Protein Drugs Sales by Country
      • 8.2.2 Europe Bioengineered Protein Drugs Revenue by Country
      • 8.2.3 Germany
      • 8.2.4 France
      • 8.2.5 U.K.
      • 8.2.6 Italy
      • 8.2.7 Russia

    9 Asia Pacific

    • 9.1 Asia Pacific Bioengineered Protein Drugs Market Size YoY Growth 2015-2026
    • 9.2 Asia Pacific Bioengineered Protein Drugs Market Facts & Figures by Country
      • 9.2.1 Asia Pacific Bioengineered Protein Drugs Sales by Region (2015-2020)
      • 9.2.2 Asia Pacific Bioengineered Protein Drugs Revenue by Region
      • 9.2.3 China
      • 9.2.4 Japan
      • 9.2.5 South Korea
      • 9.2.6 India
      • 9.2.7 Australia
      • 9.2.8 Taiwan
      • 9.2.9 Indonesia
      • 9.2.10 Thailand
      • 9.2.11 Malaysia
      • 9.2.12 Philippines
      • 9.2.13 Vietnam

    10 Latin America

    • 10.1 Latin America Bioengineered Protein Drugs Market Size YoY Growth 2015-2026
    • 10.2 Latin America Bioengineered Protein Drugs Market Facts & Figures by Country
      • 10.2.1 Latin America Bioengineered Protein Drugs Sales by Country
      • 10.2.2 Latin America Bioengineered Protein Drugs Revenue by Country
      • 10.2.3 Mexico
      • 10.2.4 Brazil
      • 10.2.5 Argentina

    11 Middle East and Africa

    • 11.1 Middle East and Africa Bioengineered Protein Drugs Market Size YoY Growth 2015-2026
    • 11.2 Middle East and Africa Bioengineered Protein Drugs Market Facts & Figures by Country
      • 11.2.1 Middle East and Africa Bioengineered Protein Drugs Sales by Country
      • 11.2.2 Middle East and Africa Bioengineered Protein Drugs Revenue by Country
      • 11.2.3 Turkey
      • 11.2.4 Saudi Arabia
      • 11.2.5 U.A.E

    12 Company Profiles

    • 12.1 Abbot
      • 12.1.1 Abbot Corporation Information
      • 12.1.2 Abbot Description and Business Overview
      • 12.1.3 Abbot Sales, Revenue and Gross Margin (2015-2020)
      • 12.1.4 Abbot Bioengineered Protein Drugs Products Offered
      • 12.1.5 Abbot Recent Development
    • 12.2 Amgen
      • 12.2.1 Amgen Corporation Information
      • 12.2.2 Amgen Description and Business Overview
      • 12.2.3 Amgen Sales, Revenue and Gross Margin (2015-2020)
      • 12.2.4 Amgen Bioengineered Protein Drugs Products Offered
      • 12.2.5 Amgen Recent Development
    • 12.3 Baxter
      • 12.3.1 Baxter Corporation Information
      • 12.3.2 Baxter Description and Business Overview
      • 12.3.3 Baxter Sales, Revenue and Gross Margin (2015-2020)
      • 12.3.4 Baxter Bioengineered Protein Drugs Products Offered
      • 12.3.5 Baxter Recent Development
    • 12.4 Bayer
      • 12.4.1 Bayer Corporation Information
      • 12.4.2 Bayer Description and Business Overview
      • 12.4.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
      • 12.4.4 Bayer Bioengineered Protein Drugs Products Offered
      • 12.4.5 Bayer Recent Development
    • 12.5 Eli Lilly
      • 12.5.1 Eli Lilly Corporation Information
      • 12.5.2 Eli Lilly Description and Business Overview
      • 12.5.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
      • 12.5.4 Eli Lilly Bioengineered Protein Drugs Products Offered
      • 12.5.5 Eli Lilly Recent Development
    • 12.6 GlaxoSmithKline
      • 12.6.1 GlaxoSmithKline Corporation Information
      • 12.6.2 GlaxoSmithKline Description and Business Overview
      • 12.6.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
      • 12.6.4 GlaxoSmithKline Bioengineered Protein Drugs Products Offered
      • 12.6.5 GlaxoSmithKline Recent Development
    • 12.7 Fresenius Kabi
      • 12.7.1 Fresenius Kabi Corporation Information
      • 12.7.2 Fresenius Kabi Description and Business Overview
      • 12.7.3 Fresenius Kabi Sales, Revenue and Gross Margin (2015-2020)
      • 12.7.4 Fresenius Kabi Bioengineered Protein Drugs Products Offered
      • 12.7.5 Fresenius Kabi Recent Development
    • 12.8 Hoffman-la-Roche
      • 12.8.1 Hoffman-la-Roche Corporation Information
      • 12.8.2 Hoffman-la-Roche Description and Business Overview
      • 12.8.3 Hoffman-la-Roche Sales, Revenue and Gross Margin (2015-2020)
      • 12.8.4 Hoffman-la-Roche Bioengineered Protein Drugs Products Offered
      • 12.8.5 Hoffman-la-Roche Recent Development
    • 12.9 Johnson & Johnson
      • 12.9.1 Johnson & Johnson Corporation Information
      • 12.9.2 Johnson & Johnson Description and Business Overview
      • 12.9.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
      • 12.9.4 Johnson & Johnson Bioengineered Protein Drugs Products Offered
      • 12.9.5 Johnson & Johnson Recent Development
    • 12.10 Merck
      • 12.10.1 Merck Corporation Information
      • 12.10.2 Merck Description and Business Overview
      • 12.10.3 Merck Sales, Revenue and Gross Margin (2015-2020)
      • 12.10.4 Merck Bioengineered Protein Drugs Products Offered
      • 12.10.5 Merck Recent Development
    • 12.11 Abbot
      • 12.11.1 Abbot Corporation Information
      • 12.11.2 Abbot Description and Business Overview
      • 12.11.3 Abbot Sales, Revenue and Gross Margin (2015-2020)
      • 12.11.4 Abbot Bioengineered Protein Drugs Products Offered
      • 12.11.5 Abbot Recent Development

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Porter’s Five Forces Analysis
    • 13.5 Primary Interviews with Key Bioengineered Protein Drugs Players (Opinion Leaders)

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Bioengineered Protein Drugs Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      Bioengineered Protein Drugs market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Bioengineered Protein Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

      Segment by Type, the Bioengineered Protein Drugs market is segmented into
      Recombinant protein drugs
      Peptide hormones
      Vaccines
      Therapeutic enzymes
      Monoclonal antibodies
      Cytokines
      Replacement proteins
      Peptide antibiotics
      Blood products

      Segment by Application, the Bioengineered Protein Drugs market is segmented into
      Fractionation
      Bioreactors and microbial cell fermentation
      Genetic engineering
      Genetically modified organisms
      Pharming
      Bioengineered protein drugs produced by transgenic microorganisms, plants and animals
      Cell culture
      Others

      Regional and Country-level Analysis
      The Bioengineered Protein Drugs market is analysed and market size information is provided by regions (countries).
      The key regions covered in the Bioengineered Protein Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
      The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

      Competitive Landscape and Bioengineered Protein Drugs Market Share Analysis
      Bioengineered Protein Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Bioengineered Protein Drugs business, the date to enter into the Bioengineered Protein Drugs market, Bioengineered Protein Drugs product introduction, recent developments, etc.
      The major vendors covered:
      Abbot
      Amgen
      Baxter
      Bayer
      Eli Lilly
      GlaxoSmithKline
      Fresenius Kabi
      Hoffman-la-Roche
      Johnson & Johnson
      Merck



      Summary:
      Bioengineered Protein Drugs Market Research Report is about Bioengineered Protein Drugs Industry study. Get complete Bioengineered Protein Drugs market research report published after Market Study, Industrial Analysis with Trends & Statistics. Bioengineered Protein Drugs Market Report is a syndicated report for Investors and Manufacturer to understand Market Demand, Growth, trends and Factor Influencing market in upcoming years.



      REPORT YOU MIGHT BE INTERESTED